Veterinary Medicines

Canigen DHA2PPi/LR liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań dla psów

Authorised
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain Lederle VR128, Live
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
  • Canine parainfluenza virus, strain Manhattan, Live
  • Rabies virus, strain VP12, Inactivated
Download as PDF

Product identification

Medicine name:
Canigen DHA2PPi/LR liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań dla psów
Active substance:
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain Lederle VR128, Live
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
  • Canine parainfluenza virus, strain Manhattan, Live
  • Rabies virus, strain VP12, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain Cornell 780916, Live
    6.80
    log10 50% cell culture infectious dose
    /
    1.00
    log10 50% cell culture infectious dose
  • Canine adenovirus 2, strain Manhattan, Live
    6.00
    log10 50% cell culture infectious dose
    /
    1.00
    log10 50% cell culture infectious dose
  • Canine distemper virus, strain Lederle VR128, Live
    4.90
    log10 50% cell culture infectious dose
    /
    1.00
    log10 50% cell culture infectious dose
  • Leptospira interrogans, serovar Canicola, Inactivated
    833.00
    million organisms
    /
    1.00
    million organisms
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
    833.00
    million organisms
    /
    1.00
    million organisms
  • Canine parainfluenza virus, strain Manhattan, Live
    6.90
    log10 50% cell culture infectious dose
    /
    1.00
    log10 50% cell culture infectious dose
  • Rabies virus, strain VP12, Inactivated
    1.00
    international unit(s)
    /
    1.00
    international unit(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1484
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 9/05/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 9/05/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 9/05/2025
Download